milameline milameline milameline (ci-979, pd-129,409, ru-35,926) is a non-selective muscarinic acetylcholine receptor partial agonist with cognition-acting properties that was being investigated for the treatment of alzheimer's disease, but produced poor results in clinical trials and was subsequently discontinued. changing the o-methyl aldoxime to an o-propargyl oxime instead gives a separate molecule called ru 35986. milamelineclinical dataatc codenoneidentifiers iupac name (e)-n-methoxy-1-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)methanimine cas number139886-32-1pubchem cid9571002iuphar/bps301chemspider7845468uniir9x77r42fnecha infocard100.220.595 chemical and physical dataformulac8h14n2omolar mass154.213 g·mol−13d model (jsmol)interactive image smiles n(/oc)=c\c1=c\ccn(c)c1